As digital patient recruitment for clinical trials becomes more accepted and competitive, we continually shift our focus on the channels that consistently outperform the rest of the pack.
Last week, Clariness hosted our (first-ever) The Patient’s Voice, a seminar designed to promote patient-focused drug development, and generate new ideas for researchers and drug makers to consider during clinical development planning, feasibility and execution.
Cardiovascular outcome studies present unique challenges by the sheer volume of patients involved in these studies alone. Recruitment costs can easily escalate into sky-high digits, if outreach channels, screening mechanisms and patient referrals are not properly managed.
A patient is a person who receives medical care. As a registered nurse, I delivered care to patients in the hospital and homecare setting, but there are many other settings in which patients can receive medical care.
There are many parallels between patient centric drug development and good web design. Ensuring the best user experience begins with an understanding of users.
Scientific efforts to prevent, manage or better understand Alzheimer’s disease progression make news headlines every day. In today’s biopharmaceutical product pipeline, there are more than 300 open Alzheimer’s disease clinical trials, according to a cursory search on Clinicaltrials.gov.
“When we conducted our first patient survey, it was seen as novel at the time. Now it’s a best practice.”
The calls for patient-centric drug development are getting louder. Patient centricity, while in the spotlight now, has been taking shape for nearly 30 years, although fragmented and with variable effects on health outcomes
Facebook vs Google for clinical trial patient recruitment? While Facebook operates with the strength of a major broadcast network with more than a 1 billion users, Google remains as the world’s digital superpower by virtue of successful bundling of multiple leading web platforms together.
Successful clinical research relies on effective patient recruitment and investigator site performance. The two go hand in hand. That’s why a key part of our enrollment strategy goes beyond patient outreach and focuses on site support throughout the clinical trial process.
Subscribe to our monthly newsletter for pharma news, company insights and free downloads.